Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu Logo Principal Rowett

Gut microbiology

Invited speakers

SESSION 1 - Recent advances in gut microbial diversity and function

berry

David Berry is an Assistant Professor of Human and Animal Microbiome in the Department of Microbiology and Ecosystem Science, University of Vienna. Berry’s major research interests lie in developing novel single cell and imaging tools to probe microbial ecophysiology and activity in the gut microbiome. His group is active in the study of several fundamental aspects of gut microbiology such as evolution and ecology of members of the gut microbiota, the composition and function of the mucus-associated microbiota, and microbial interactions in complex compound degradation. Additionally, his group is interested in the role of the microbiota in intestinal inflammation, colonization resistance to enteric pathogens, and cancer. Berry’s group uses chemical and isotope imaging tools in combination with sequencing-based approaches to understand the complex microbial ecosystem that lives in an intimate symbiosis with its host and how it impacts host nutrition and health.

SESSION 2 - Microbial diversity and metabolism

INBOX)18776

Bryan White is a Professor of Animal Sciences in the Carl R. Woese Institute for Genomic Biology, and the Director of the Mayo Clinic/University of Illinois Strategic Alliance for Technology-Based Healthcare.  White’s major research interests are in using microbial physiology, genomics and metagenomics, and ecology to understand host-microbe interactions in vertebrates.  His laboratory is using animal models that address fiber utilization in domestic animal species for understanding nutrition and food safety.  His work with human and non-human primate gastrointestinal and reproductive tracts address the role of the microbiome in women’s reproductive health, the development of autoimmune diseases, cancer etiology and prevention, and evolution of the host.  This includes applying high throughput genomic technologies to identify microbial biomarkers for personalized medical diagnostics; genomic information physicians could use as predictors of risk that positively impact clinical outcomes.

SESSION 3 - Crosstalk between the gut microbiota and the host

article

Dr Primrose Freestone (BSc (Hons), PhD, PGCE, FRSB FHEA) is a Lecturer in Clinical Microbiology and Inventor at the University of Leicester, UK. She is a biochemist by training, with extensive experience in bacterial physiology and biochemistry, including bacterial protein phosphorylation (she was the first to identify tyrosine phosphorylation as a regulatory mechanism in bacteria).Currently, Dr Freestone’s research interests are focused on the relationship between stress and infection. She is a co-founder and internationally recognised leader in the field of Microbial Endocrinology, a research discipline which represents the intersection of microbiology, endocrinology and neurophysiology. Microbial Endocrinology is directed at providing a new framework with which to examine and understand the ability of microorganisms to interact with a host in both health and disease. Dr Freestone’s Microbial Endocrinology research interests are focused on the complex relationship of the host and their microflora, particularly the effects of exposure to stress hormones such as adrenaline and noradrenaline on bacterial growth and virulence. She co-published the first book on Microbial Endocrinology and has over 60 research papers.

SESSION 4 - Interplay between gut microbiome and the environment

Denman_2015

Stuart Denman is a senior research scientist with CSIRO Agriculture based at the Queensland Bioscience Precinct and works within the Animal Health, Welfare and Microbiology research group. Denman’s major research interests are in using ‘omics’ technologies to produce new insights into the microbial world, and from which, improved methods for monitoring and adjustment of the gut microbiota might be achieved. His main focus has been on investigating the effectiveness of methane abatement strategies by understanding the variations in microbial population structure and processors in ruminant species and drawing parallels with other low methane gut systems. With the aim of devising methods for manipulating these populations towards defined functional community structures.

SESSION 5 - Impact of diet on gut microbiota

H.Flint3

Harry Flint holds a personal Professorship at the Rowett Institute of Nutrition and Health, University of Aberdeen. He obtained his BSc and PhD in Genetics from the University of Edinburgh and subsequently held appointments at the Universities of Nottingham, the West Indies and Edinburgh. Over the past 30 years spent at the Rowett, his research has focussed on the impact of commensal and symbiotic micro-organisms in the mammalian gut on nutrition and health. Current research combines molecular approaches with cultural microbiology to uncover the roles of human colonic gut bacteria in fermentative metabolism and the degradation of dietary components, especially resistant starches and plant cell wall polysaccharides. Harry is a Governor of the British Nutrition Foundation and a recent Section Editor for the European Journal of Nutrition. He has published more than 240 primary papers, review articles and book chapters.